Abstract

Ecological studies have suggested fewer COVID-19 morbidities and mortalities in Bacillus Calmette-Guérin (BCG)-vaccinated countries than BCG-non-vaccinated countries. However, these studies obtained data during the early phase of the pandemic and did not adjust for potential confounders, including PCR-test numbers per population (PCR-tests). Currently-more than four months after declaration of the pandemic-the BCG-hypothesis needs reexamining. An ecological study was conducted by obtaining data of 61 factors in 173 countries, including BCG vaccine coverage (%), using morbidity and mortality as outcomes, obtained from open resources. 'Urban population (%)' and 'insufficient physical activity (%)' in each country was positively associated with morbidity, but not mortality, after adjustment for PCR-tests. On the other hand, recent BCG vaccine coverage (%) was negatively associated with mortality, but not morbidity, even with adjustment for percentage of the population ≥ 60 years of age, morbidity, PCR-tests and other factors. The results of this study generated a hypothesis that a national BCG vaccination program seems to be associated with reduced mortality of COVID-19, although this needs to be further examined and proved by randomized clinical trials.

MeSH

Environmental Exposure, Mortality, Vaccines, Vaccination, Covid-19, Morbidity, Pandemics

Cited by

• Efficacy of Bacille Calmette-Guérin Against COVID-19 Hospitalisation: A Meta-Analysis and Systematic Review of Randomised Control Trials. Vaccines (Basel), 2025
• Spurious early ecological association suggesting BCG vaccination effectiveness for COVID-19. PLoS One, 2022
• COVID-19 and Beyond: Exploring Public Health Benefits from Non-Specific Effects of BCG Vaccination. Microorganisms, 2021
• BCG vaccination at birth and COVID-19: a case-control study among U.S. military Veterans. Hum Vaccin Immunother, 2022
• BCG vaccination potential for COVID-19: an analytical approach. Hum Vaccin Immunother, 2021
• The Natural Effect of BCG Vaccination on COVID-19: The Debate Continues. Front Immunol, 2022
• Revisiting the potential role of BCG and MMR vaccines in COVID-19. Sci Prog, 2022
• BCG Vaccination: A potential tool against COVID-19 and COVID-19-like Black Swan incidents. Int Immunopharmacol, 2022
• Association of Flu specific and SARS-CoV-2 specific CD4 T cell responses in SARS-CoV-2 infected asymptomatic heath care workers. Vaccine, 2021
• Parallels in the pathogenesis of SARS-CoV-2 and : a synergistic or antagonistic alliance? Future Microbiol, 2021
• Does BCG provide long-term protection against SARS-CoV-2 infection? A case-control study in Quebec, Canada. Vaccine, 2021
• The association between malaria prevalence and COVID-19 mortality. BMC Infect Dis, 2021
• Pathogenesis of SARS-CoV-2 and Coinfection. Front Immunol, 2022
• Effect of BCG on Respiratory Complications Caused by COVID-19: A Scoping Review. Int J Gen Med, 2023
• Delivery of spike-RBD by bacterial type three secretion system for SARS-CoV-2 vaccine development. Front Immunol, 2023
• Perspectives About Modulating Host Immune System in Targeting SARS-CoV-2 in India. Front Genet, 2021
• BCG Vaccine-Induced Trained Immunity and COVID-19: Protective or Bystander? Infect Drug Resist, 2021
• COVID-19 pandemic: Water, sanitation and hygiene (WASH) as a critical control measure remains a major challenge in low-income countries. Water Res, 2021
• Does Bacille Calmette-Guérin Vaccination Provides Protection against COVID-19: A Systematic Review and Meta-analysis. Indian J Community Med, 2022
• A Comparative Analysis on the Social Determinants of COVID-19 Vaccination Coverage in Fragile and Conflict Affected Settings and Non-fragile and Conflict Affected Settings. Int J Health Policy Manag, 2023